Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)

HKG:2190 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 8, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	7,538	7,792	3,767	4,075	4,268	8,476
Market Cap Growth	39.83%	106.85%	-7.55%	-4.52%	-49.65%	-
Enterprise Value	5,682	6,114	2,597	2,287	1,002	7,606
Last Close Price	22.48	23.10	11.71	12.37	12.77	25.35
PE Ratio	26.75	28.66	35.31	-	-	-
Forward PE	18.66	23.84	19.34	62.73	-	-
PS Ratio	6.41	6.62	4.52	7.01	11.30	38.81
PB Ratio	2.10	2.17	1.14	1.21	1.22	2.20
P/TBV Ratio	2.12	2.20	1.15	1.22	1.22	2.20
P/FCF Ratio	24.76	25.59	-	-	-	-
P/OCF Ratio	17.60	18.20	20.34	37.58	-	-
EV/Sales Ratio	4.83	5.20	3.12	3.93	2.65	34.83
EV/EBITDA Ratio	21.60	23.66	26.69	-	-	-
EV/EBIT Ratio	25.68	27.63	41.53	-	-	-
EV/FCF Ratio	18.66	20.08	-	-	-	-
Debt / Equity Ratio	0.02	0.02	0.03	0.02	0.01	0.00
Debt / EBITDA Ratio	0.27	0.27	0.94	-	-	-
Debt / FCF Ratio	0.23	0.23	-	-	-	-
Net Debt / Equity Ratio	-0.52	-0.52	-0.38	-0.48	-0.60	-0.93
Net Debt / EBITDA Ratio	-7.18	-7.18	-13.04	11.51	9.08	14.00
Net Debt / FCF Ratio	-6.10	-6.10	69.05	15.73	8.17	15.02
Asset Turnover	0.30	0.30	0.23	0.16	0.10	0.10
Inventory Turnover	1.44	1.44	1.09	0.82	0.67	0.76
Quick Ratio	5.38	5.38	3.89	4.80	12.32	30.22
Current Ratio	5.98	5.98	4.58	5.40	13.56	31.14
Return on Equity (ROE)	7.72%	7.72%	3.26%	-2.56%	-3.64%	-11.19%
Return on Assets (ROA)	3.54%	3.54%	1.08%	-2.93%	-4.30%	-7.27%
Return on Capital Employed (ROCE)	6.10%	6.10%	1.90%	-5.10%	-7.20%	-6.90%
Earnings Yield	3.61%	3.49%	2.83%	-2.13%	-3.01%	-2.89%
FCF Yield	4.04%	3.91%	-0.49%	-2.50%	-5.99%	-2.81%
Dividend Yield	1.13%	1.06%	0.91%	-	-	-
Payout Ratio	13.38%	13.38%	-	-	-	-
Buyback Yield / Dilution	1.34%	1.34%	0.22%	0.51%	-12.15%	-51.26%
Total Shareholder Return	2.46%	2.40%	1.13%	0.51%	-12.15%	-51.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.